Literature DB >> 21475213

Mutation-specific cystic fibrosis treatments on verge of approval.

Elie Dolgin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475213     DOI: 10.1038/nm0411-396

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR.

Authors:  Heidi M Sampson; Renaud Robert; Jie Liao; Elizabeth Matthes; Graeme W Carlile; John W Hanrahan; David Y Thomas
Journal:  Chem Biol       Date:  2011-02-25

2.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Authors:  Darren M Hutt; David Herman; Ana P C Rodrigues; Sabrina Noel; Joseph M Pilewski; Jeanne Matteson; Ben Hoch; Wendy Kellner; Jeffery W Kelly; Andre Schmidt; Philip J Thomas; Yoshihiro Matsumura; William R Skach; Martina Gentzsch; John R Riordan; Eric J Sorscher; Tsukasa Okiyoneda; John R Yates; Gergely L Lukacs; Raymond A Frizzell; Gerard Manning; Joel M Gottesfeld; William E Balch
Journal:  Nat Chem Biol       Date:  2009-12-06       Impact factor: 15.040

5.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

  5 in total
  2 in total

1.  Personalized psychiatry: many questions, fewer answers.

Authors:  Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

2.  Exon-skipping drug pulls ahead in muscular dystrophy field.

Authors:  Alisa Opar
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.